mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.3 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.4 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.4 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |